Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Odense – page 18

483 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Odense at a glance
483
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

483 trials in Odense

Open in trial search

Acute lymphocytic leukaemia

Recruiting

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Prostate cancer+1

Recruiting

Study on Atorvastatin's Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Pirkanmaan hyvinvointialue

Pulmonary embolism

Recruiting

Study on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Region Hovedstaden

Alcoholic liver disease

Recruiting

Study on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Cardiac arrest+1

Recruiting

Study on the Effects of Bisoprolol Fumarate, Hydrochlorothiazide, and Metoprolol in Patients with Idiopathic Ventricular Fibrillation After Cardiac Arrest

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atenolol
  • Sponsor:Region Hovedstaden

Myocardial ischaemia+1

Recruiting

Study on Dexamethasone and Olanzapine for Patients Undergoing Heart Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Olanzapine
  • Sponsor:Region Hovedstaden

Glomerulonephritis membranous+1

Recruiting

Study on the Safety and Effects of AP1189 for Patients with Idiopathic Membranous Nephropathy and Severe Proteinuria

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Resomelagon
  • Sponsor:Synact Pharma ApS

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Chronic obstructive pulmonary disease

Not yet recruiting

Study of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Peripheral arterial occlusive disease

Not yet recruiting

Efficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dermatitis atopic

Not yet recruiting

Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Systemic scleroderma+1

Not yet recruiting

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Scleroderma Research Foundation

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Odense

What the registry says about research in the country

01 Respiratory and Pulmonary Research

Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.

  • Pulmonary Fibrosis Treatment
  • Nasal Polyps Management
  • Chronic Rhinosinusitis

Trials aim to assess innovative treatments and monitor long-term disease control.

02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.

  • Cancer-Related Fatigue
  • Advanced Breast Cancer
  • Prostate Cancer Therapy

Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.

03 Autoimmune and Inflammatory Conditions

Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.

  • Gastrointestinal Disorders
  • Immune System Disorders
  • Chronic Inflammatory Conditions

Trials assess both established and experimental therapies for inflammatory conditions.

04 Cardiovascular and Renal Studies

Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.

  • Kidney Transplantation
  • Cardiac Conditions
  • Renal Disorders

Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.